2019-06994. Center for Scientific Review; Notice of Closed Meetings  

  • Start Preamble

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended, notice is hereby given of the following meetings.

    The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: Center for Scientific Review Special Emphasis Panel; RFA-MH-19-425: Revision Application for Implementation Research to Inform and Enhance PEPFAR HIV Pre-exposure Prophylaxis.

    Date: April 29, 2019.

    Time: 12:00 p.m. to 6:00 p.m.

    Agenda: To review and evaluate grant applications.

    Place: National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20892 (Telephone Conference Call).

    Contact Person: Jose H. Guerrier, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 5218, MSC 7852, Bethesda, MD 20892, 301-435-1137, guerriej@csr.nih.gov.

    Name of Committee: Center for Scientific Review Special Emphasis Panel; RFA-MH-19-425: Revision Application for Implementation Research to Inform and Enhance PEPFAR HIV Pre-exposure Prophylaxis.

    Date: April 29, 2019.

    Time: 12:00 p.m. to 4:00 p.m.Start Printed Page 14122

    Agenda: To review and evaluate grant applications.

    Place: National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20892 (Telephone Conference Call).

    Contact Person: Mark P. Rubert, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 5218, MSC 7852, Bethesda, MD 20892, 301-435-1775, rubertm@csr.nih.gov.

    Name of Committee: Center for Scientific Review Special Emphasis Panel; PAR-16-274 and PAR-16-275: Adverse Drug Reaction Research.

    Date: May 1, 2019.

    Time: 1:00 p.m. to 3:00 p.m.

    Agenda: To review and evaluate grant applications.

    Place: National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting).

    Contact Person: Alexander D. Politis, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 3210, MSC 7808, Bethesda, MD 20892, (301) 435-1150, politisa@csr.nih.gov.

    (Catalogue of Federal Domestic Assistance Program Nos. 93.306, Comparative Medicine; 93.333, Clinical Research, 93.306, 93.333, 93.337, 93.393-93.396, 93.837-93.844, 93.846-93.878, 93.892, 93.893, National Institutes of Health, HHS)

    Start Signature

    Dated: April 4, 2019.

    Natasha M. Copeland,

    Program Analyst, Office of Federal Advisory Committee Policy.

    End Signature End Preamble

    [FR Doc. 2019-06994 Filed 4-8-19; 8:45 am]

    BILLING CODE 4140-01-P

Document Information

Published:
04/09/2019
Department:
National Institutes of Health
Entry Type:
Notice
Document Number:
2019-06994
Dates:
April 29, 2019.
Pages:
14121-14122 (2 pages)
PDF File:
2019-06994.pdf